Women with breast cancer who receive compounds that stimulate white blood cell production to help their bodies better tolerate chemotherapy are at an increased risk of developing a type of leukemia or a condition called myelodysplastic syndrome, according to a new study in the February 7, Journal of the National Cancer Institute.
When cells go about the business of dividing, they can get sidelined. Maybe there aren’t enough nutrients. Maybe there aren’t the right signals to resume multiplying. Either way, cells go quiet.
March is AMD Awareness Month in March, and the American Academy of Ophthalmology wants to remind people that although AMD is incurable, there are new treatments that can usually recover lost vision and prevent further vision loss from the disease.
Low levels of toxic substances cause critical stem cells in the central nervous system to prematurely shut down. That is the conclusion of a study published today in the on-line journal PLoS Biology.
Wielding a palette of chromosome paints, scientists at the Salk Institute for Biological Studies have taken a step closer to understanding the relationship between aging and cancer by visualizing chromosomes of cells from patients with a heritable premature aging disease known as Werner Syndrome.
Nearly 42,000 additional procedures in wait time priority areas were performed in Canada outside Quebec in 2005?2006 compared to the previous year, according to a new study by the Canadian Institute for Health Information (CIHI).
For many women, irregular or infrequent menstrual cycles may not sound like such a bad thing. But a condition that can cause irregular periods ? polycystic ovary syndrome, or PCOS ? can present women with numerous health concerns, ranging from excess hair growth to fertility issues to an increased risk of heart disease and diabetes.
Lavender and tea tree oils found in some shampoos, soaps and lotions can temporarily leave boys with enlarged breasts in rare cases, apparently by disrupting their hormonal balance, a preliminary study suggests.
An approved drug for fighting obesity is helping scientists at Wake Forest University School of Medicine uncover clues about how to stop the growth of cancerous tumors.
AkaRx, Inc., a Paramus, New Jersey biopharmaceutical company announced today that they have licensed from BeartownPharma, Inc., of Underhill, Vermont the patents for a new drug being developed for the treatment of patients with thyroid cancer.